JP2023525476A5 - - Google Patents

Info

Publication number
JP2023525476A5
JP2023525476A5 JP2022564157A JP2022564157A JP2023525476A5 JP 2023525476 A5 JP2023525476 A5 JP 2023525476A5 JP 2022564157 A JP2022564157 A JP 2022564157A JP 2022564157 A JP2022564157 A JP 2022564157A JP 2023525476 A5 JP2023525476 A5 JP 2023525476A5
Authority
JP
Japan
Prior art keywords
cns
synthetic
expression cassette
vector
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022564157A
Other languages
English (en)
Japanese (ja)
Other versions
JP7807393B2 (ja
JP2023525476A (ja
Filing date
Publication date
Priority claimed from GBGB2005732.9A external-priority patent/GB202005732D0/en
Application filed filed Critical
Publication of JP2023525476A publication Critical patent/JP2023525476A/ja
Publication of JP2023525476A5 publication Critical patent/JP2023525476A5/ja
Application granted granted Critical
Publication of JP7807393B2 publication Critical patent/JP7807393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022564157A 2020-04-20 2021-04-19 調節核酸配列 Active JP7807393B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2005732.9 2020-04-20
GBGB2005732.9A GB202005732D0 (en) 2020-04-20 2020-04-20 Regulatory nucleic acid sequences
PCT/GB2021/050939 WO2021214443A1 (en) 2020-04-20 2021-04-19 Regulatory nucleic acid sequences

Publications (3)

Publication Number Publication Date
JP2023525476A JP2023525476A (ja) 2023-06-16
JP2023525476A5 true JP2023525476A5 (https=) 2024-05-01
JP7807393B2 JP7807393B2 (ja) 2026-01-27

Family

ID=70860129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022564157A Active JP7807393B2 (ja) 2020-04-20 2021-04-19 調節核酸配列

Country Status (8)

Country Link
US (1) US20230143758A1 (https=)
EP (1) EP4139466A1 (https=)
JP (1) JP7807393B2 (https=)
CN (1) CN115702246A (https=)
AU (1) AU2021260914A1 (https=)
CA (1) CA3176038A1 (https=)
GB (1) GB202005732D0 (https=)
WO (1) WO2021214443A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025503910A (ja) * 2022-01-27 2025-02-06 アスクレピオス バイオファーマシューティカル， インコーポレイテッド 神経疾患を処置するための組成物

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
FR2640638B1 (fr) 1988-12-20 1991-02-15 Commissariat Energie Atomique Bioreacteur et dispositif pour la culture de cellules animales
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6281010B1 (en) 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
US5756283A (en) 1995-06-05 1998-05-26 The Trustees Of The University Of Pennsylvania Method for improved production of recombinant adeno-associated viruses for gene therapy
EP0931158A1 (en) 1996-09-06 1999-07-28 The Trustees Of The University Of Pennsylvania An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
WO1998022588A2 (en) 1996-11-20 1998-05-28 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
WO1999014354A1 (en) 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
EP1015619A1 (en) 1997-09-19 2000-07-05 The Trustees Of The University Of Pennsylvania Methods and cell line useful for production of recombinant adeno-associated viruses
EP1064393B1 (en) 1998-03-20 2004-12-29 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
US6953690B1 (en) 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
DE69928809T2 (de) * 1998-07-03 2006-08-31 Innogenetics N.V. Differentielle diagnose von neurodegeneration
AU780231B2 (en) 1998-11-10 2005-03-10 University Of North Carolina At Chapel Hill, The Virus vectors and methods of making and administering the same
JP4693244B2 (ja) 1999-03-18 2011-06-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
US6258595B1 (en) 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
CA2375098A1 (en) 1999-06-02 2000-12-14 Trustees Of The University Of Pennsylvania Compositions and methods useful for production of recombinant viruses which require helper viruses
JP2003523320A (ja) 1999-09-29 2003-08-05 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア ウイルスベクターの迅速なｐｅｇ改変方法、高められた遺伝子形質導入のための組成物、高められた物理的安定性を伴う組成物、およびそのための用途
US6365394B1 (en) 1999-09-29 2002-04-02 The Trustees Of The University Of Pennsylvania Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
ES2261489T3 (es) 2000-10-13 2006-11-16 Chiron Corporation Fragmentos de intron a de citomegalovirus.
US7261544B2 (en) 2003-05-21 2007-08-28 Genzyme Corporation Methods for producing preparations of recombinant AAV virions substantially free of empty capsids
SI1633772T1 (sl) 2003-06-19 2016-06-30 Genzyme Corporation AAV virioni z zmanjšano imunoreaktivnostjo in uporaba za ta namen
US7291498B2 (en) 2003-06-20 2007-11-06 The Trustees Of The University Of Pennsylvania Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
CA2528511C (en) 2003-06-20 2015-11-03 The Trustees Of The University Of Pennsylvania Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
US8106180B2 (en) 2003-08-07 2012-01-31 Whitehead Institute For Biomedical Research Methods and products for expression of micro RNAs
US20050142581A1 (en) 2003-09-04 2005-06-30 Griffey Richard H. Microrna as ligands and target molecules
WO2005056761A2 (en) 2003-12-05 2005-06-23 Massachusetts Institute Of Technology REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
US20060166363A1 (en) 2004-01-27 2006-07-27 Sergei Zolotukhin Modified baculovirus expression system for production of pseudotyped rAAV vector
EP1747277B1 (en) * 2004-04-14 2011-08-10 Agency for Science, Technology and Research Gene delivery to neuronal cells
KR100614827B1 (ko) 2004-05-06 2006-08-25 재단법인서울대학교산학협력재단 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체
IS8576A (is) * 2006-12-05 2007-01-15 Decode Genetics Genetic susceptibility variants of atrial fibrillation and stroke
EP2187898B8 (en) * 2007-09-12 2016-09-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of viral vectors carrying the cyp46a1 gene for the treatment of alzheimer's disease
WO2009074968A2 (en) * 2007-12-12 2009-06-18 Ecole Polytechnique Federale De Lausanne (Epfl) Method for predicting the efficacy of cancer therapy
US8383803B2 (en) 2008-08-11 2013-02-26 The University Of British Columbia PITX3 expression promoters
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
EP2561073B1 (en) * 2010-04-23 2016-08-24 University of Massachusetts Cns targeting aav vectors and methods of use thereof
ES2926774T3 (es) 2013-03-15 2022-10-28 Univ North Carolina Chapel Hill Métodos y composiciones para vectores AAV de doble unión de glicano
EP3808849A1 (en) 2017-08-03 2021-04-21 Voyager Therapeutics, Inc. Compositions and methods for delivery of aav
CN109536494A (zh) * 2017-10-31 2019-03-29 广东赤萌医疗科技有限公司 一种用于修复HBB1基因点突变的gRNA、基因编辑系统、表达载体和基因编辑试剂盒

Similar Documents

Publication Publication Date Title
JP7256223B2 (ja) 調節性ポリヌクレオチド
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
JP2024050553A (ja) 不整脈源性右心室心筋症における電気的機能及び心臓機能並びに心構造を回復するための遺伝子療法戦略
JP2026021360A5 (https=)
JP2023509118A5 (https=)
IL320371A (en) Gene therapy for patients with fanconi anemia
JP2020511470A5 (https=)
CN114432332A (zh) circUTRN在制备治疗心力衰竭药物中的应用、重组载体和治疗心力衰竭的药物
JP2023525476A5 (https=)
Blanco-Ocampo et al. Safe and neuroprotective vectors for long-term traumatic brain injury gene therapy
CN108888753B (zh) 酸性糖蛋白orm在制备治疗心力衰竭药物中的应用
Huang et al. Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model
WO2021228050A1 (zh) 一种诱导胶质细胞转分化为功能性神经元的方法及其应用
JP2024524270A5 (https=)
CN116019935B (zh) Ago2在制备治疗心衰或糖尿病性心肌病的药物方面的用途及其蛋白、基因、转化体
WO2023154676A1 (en) Methods for treating stroke using a stanniocalcin 2 (stc2) pharmaceutical composition
CN116574798A (zh) piR-mmu-57256903在制备防治抗癌药物所致心脏疾病的药物中的应用
CN111909246B (zh) 高效感染支持细胞的aav突变体
JP2024519955A5 (https=)
WO2022135278A1 (zh) Azd3965药物的新用途
CN114736924B (zh) 异位联合过表达Atoh1和Ikzf2再生耳蜗外毛细胞及其应用
US20250360171A1 (en) Chemogenetically gated ion channels and use thereof
WO2025018299A1 (ja) 血管平滑筋細胞指向カプシド、アデノ随伴ウイルスベクター、医薬組成物、治療方法、核酸導入方法、及びカプシド製造方法
Notkin et al. Comparative study of metrazol treatment and control observations of schizophrenia
CA2629304C (en) Combination of glycoisoforms for the treatment or prevention of septicemia, transgenic cell line that produces erythropoietin glycoisoforms, pharmaceutical composition comprising said combination